A case of osteonecrosis of the jaw in a breast cancer patient with bone metastases receiving long-term treatment with bisphosphonates

Breast Cancer

Volumn 16, Issue 2, 2009, Pages 147-150

  Mouri, Yukako ^a   Yoshida, Miwa ^a   Nakano, Shogo ^a   Yorozuya, Kyoko ^a   Fujii, Kimihito ^a   Fukutomi, Takashi ^a   Nakaoka, Toshiaki ^a   Yamada, Shiro ^a   Hara, Kazuo ^a  

^a AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Bisphosphonate; Breast cancer; Osteonecrosis

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CA 19-9 ANTIGEN; DOCETAXEL; FLUOROURACIL; PAMIDRONIC ACID; TRASTUZUMAB; TUMOR MARKER;

AGED; ARTICLE; BONE METASTASIS; BREAST CANCER; CASE REPORT; DRUG WITHDRAWAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFORMED CONSENT; JAW OSTEONECROSIS; LONG TERM CARE; MASTECTOMY; MAXILLOFACIAL SURGERY; PRIORITY JOURNAL; SPINE METASTASIS; TREATMENT DURATION;

AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DIPHOSPHONATES; FEMALE; HUMANS; JAW DISEASES; OSTEONECROSIS; SPINAL NEOPLASMS; TAXOIDS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 65249141616     PISSN: 13406868     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12282-008-0066-8     Document Type: Article

References (25)

1. SL Ruggiero B Mehrotra TJ Rosenberg SL Engroff 2004 Osteonecrosis of the jaws associated the use of bisphosphonates. A review of 63 cases J Oral Maxillofac Surg. 62 527 34
2. RE Marx 2003 Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws. A growing epidemic J Oral Maxillofac Surg. 61 1115 8
3. CA Migliorati 2003 Bisphosphonates and oral cavity avascular bone necrosis J Clin Oncol. 21 4253 4
4. J Wang NM Goodger MA Pogrel 2003 Osteonecrosis of the jaws associated with cancer chemotherapy J Oral Maxillofac Surg. 61 1104 7
5. MA Pogrel 2004 Bisphosphonates and bone necrosis J Oral Maxillofac Surg. 62 391 2
6. CH Schwartz 2004 Osteonecrosis and bisphosphonates; correlation versus caution J Oral Maxillofac Surg. 62 763 4
7. MS Greenberg 2004 Intravenous bisphosphonates and osteonecrosis Oral Surg. 98 259 60
8. JV Bagan J Murillo Y Jimenez R Poveda MA Milian JM Sanchis FJ Silvestre C Scully 2005 Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases J Oral Pathol Med. 34 120 3
9. A Bamias E Kastritis C Bamia LA Moulopoulos I Melakopoulos G Bozas V Koutsoukou D Gika A Anagnostopoulos C Papadimitriou E Terpos MA Dimopoulos 2005 Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors J Clin Oncol. 23 8580 7
10. A Wutzl G Eisenmenger M Hoffmann C Czerny D Moser P Pietschmann R Ewers A Baumann 2006 Osteonecrosis of the jaws and bisphosphonate treatment in cancer patients Wien Klin Wochenschr. 118 473 8
11. L Cavanna R Berte A Arcari P Mordenti R Pagani D Vallisa 2007 Osteonecrosis of the jaw. A newly emerging site-specific osseous pathology in patients with cancer treated with bisphosphonates. Report of five cases and review of the literature Eur J Intern Med. 18 417 422
12. T Ibrahim F Barbanti G Giorgio-Marrano L Mercatalli S Ronconi C Vicini D Amadori 2008 Osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates: a retrospective study Oncologist. 13 330 6
13. MD Anderson Cancer Center. Updated recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in cancer patients: May 2006. ASCO 2006.
14. ML Goldman N Denduluri AW Berman R Sausville JP Guadagnini DE Kleiner JS Brahim SM Swain 2006 A novel case of bisphosphonate-related osteonecrosis of the torus palatinus in a patient with metastatic breast cancer Oncology. 71 306 8
15. PM Purcell IW Boyd 2005 Bisphosphonates and osteonecrosis of the jaw Med J Aust. 182 417 8
16. G Ficarra F Beninati I Rubino A Vannucchi G Longo P Tonelli G Pini Prato 2005 Osteonecrosis of the jaws in periodontal patients with a history of bisphosphonates treatment J Clin Periodontal. 132 1123 8
17. T Iizuka SC Miller SC Marcs Jr 1992 Alveolar bone remodeling after tooth extraction in normal and osteopetrotic (ia) rats J Oral Pathol Med. 21 150 5
18. NT Bennet GS Schultz 1993 Growth factors and wound healing: biochemical properties of growth factors and their receptors Am J Surg. 165 728 37
19. P Fournier S Boissier S Filleur J Guglielmi F Cabon M Colombel P Clezardin 2002 Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats Cancer Res. 62 6538 44
20. JH Lenz B Steiner-Krammer W Schmidt R Fietkau PC Mueller KK Gundlach 2005 Does avascular necrosis of the jaws in cancer patients only occur following treatment with bisphosphonates? J Craniomaxillofac Surg. 33 395 403
21. CA Migliorati MM Schubert DE Peterson LM Seneda 2005 Bisphosphonate- associated osteonecrosis of mandibular and maxillary bone Cancer. 104 83 93
22. JH Wessel TB Dodson AI Zavras 2008 Zoledronate, smoking, and obesity are strong risk factors for oseonecrosis of the jaw: a case-control study J Oral Maxillofac Surg. 66 625 31
23. BG Durie M Katz J Crowley 2005 Osteonecrosis of the jaw and bisphosphonates N Engl J Med. 353 99 100
24. MD Melo G Obeid 2005 Osteonecrosis of the maxilla in a patient with a history of bisphosphonate therapy J Can Dent Assoc. 71 111 3
25. RE Marx Y Sawatari M Fortin V Broumand 2005 Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment J Oral Maxillofac Surg. 63 1567 75